T1D is marked by the destruction of pancreatic β cells, mainly driven by CD4+ and CD8+ T cells, resulting in inadequate insulin production and a lifelong need for external insulin therapy to alleviate symptoms (59). Here, CD8A is linked to type 1 diabetes mellitus.